Trial Profile
Rosuvastatin may stabilize atherosclerotic aortic plaque: transesophageal echocardiographic study in the EPISTEME trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms EPISTEME
- 01 Feb 2016 New trial record